Phase II Trial to Modulate Intermediate Endpoint Biomarkers in Former and Current Smokers
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find out if an investigational combination drug called Lovaza
(made with fish oils)+Curcumin C3 Complex (made from a root called curcumin) can help reduce
the size of lung nodules. Researchers also want to find out if the combination of
Lovaza+Curcumin C3 Complex is safe and tolerable.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute